The US could be the beneficiary of a potential blanket ban on the use of PFAS, better known as ‘forever chemicals’.

The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

Key Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...

The metaverse hype is over, but developer Cassette Group has been working with Pfizer to realise its forgotten potential.

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

Many dog owners have already heard about the FDA warning and seen the articles on the terrible side effects experienced by ...

The lawsuit alleges the price increases EpiPen, used to treat severe allergic reactions, prevented other similar medications ...

The U.S. government targets Novo Nordisk's drugs, including Ozempic and Wegovy, for Medicare price negotiations in 2027.

The U.S. government targets 15 high-cost medications for Medicare price negotiations for 2027, under the Inflation Reduction ...